O01: Outcomes of newborn screening for mucopolysaccharidosis type I: Boston Children’s Hospital single center experience*

類似資料

• P001: Single center experience with the Massachusetts State Newborn Screening Pilot Program for mucopolysaccharidosis type I, Pompe disease and X-linked adrenoleukodystrophy
  著者:: Christina Grassie, 等
  出版事項: (2023-01-01)
• P028: Improved neurocognitive outcomes in neuronopathic mucopolysaccharidosis type II: A case of early hematopoietic stem cell transplant
  著者:: Emma Michl, 等
  出版事項: (2023-01-01)
• Newborn Screening for Mucopolysaccharidosis Type II in Illinois: An Update
  著者:: Barbara K. Burton, 等
  出版事項: (2020-09-01)
• A Biochemical Platform to Define the Relative Specific Activity of <i>IDUA</i> Variants Identified by Newborn Screening
  著者:: Seok-Ho Yu, 等
  出版事項: (2020-11-01)
• Harmonization of Newborn Screening Results for Pompe Disease and Mucopolysaccharidosis Type I
  著者:: M. Christine Dorley, 等
  出版事項: (2023-02-01)